Solutions for Collaborative Networked Pharma Research

In a shift from the long established business model, life sciences research is now often carried out in collaborative networks that include pharma companies, biotechs, CROs, academia and research institutes working together on a single research project and jointly developing intellectual property.

An estimated 30-50% of all spending on discovery projects is now spent outside the sponsoring organisation and up to 60% of all innovation in top pharma companies may be derived from external sources.

At the same time many of these joint discovery projects are failing for a variety of reasons, including poor communication and data/reporting inconsistencies.

Read this Whitepaper from Dotmatics to explore ways to optimize collaborative networked pharma research and access a case study from one of pharma's top companies. 

Download your copy today

Benefits of Reading this Whitepaper

Challenges Addressed

Enable all team members from multiple organisations, cultures and geographies to continuously communicate around the scientific objects within a project. Track reagents and samples across all of the partners in a joint project. Avoid the tangled logistics of scheduling work as more organisations become involved in a project.

Arduous, error prone exchanges: Data exchange, collaboration and communication within an externalised project is often facilitated by email and/or secure document exchange which is time consuming, requires error prone manual data manipulation and complicates IP management.  Security risks: Sponsor companies sometimes provide partners with access to their internal systems –  this leads to potential  security risks.  Complicated project tracking: managing a project and monitoring its progress becomes much harder once external partners are involved.

Download PDF Attachment